Peter A Forsyth

Peter A Forsyth

UNVERIFIED PROFILE

Are you Peter A Forsyth?   Register this Author

Register author
Peter A Forsyth

Peter A Forsyth

Publications by authors named "Peter A Forsyth"

Are you Peter A Forsyth?   Register this Author

71Publications

1482Reads

8Profile Views

Breast leptomeningeal disease: a review of current practices and updates on management.

Breast Cancer Res Treat 2019 Sep 17;177(2):277-294. Epub 2019 Jun 17.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05317-6DOI Listing
September 2019

CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

J Neurooncol 2019 Sep 9;144(3):583-589. Epub 2019 Aug 9.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03260-6DOI Listing
September 2019

Viral Therapy Gets Personal: A Potential Gene Signature to Predict Susceptibility to Measles Virus Oncolysis.

J Natl Cancer Inst 2018 10;110(10):1139-1140

Immunology, Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy061DOI Listing
October 2018

The Blood Brain Barrier and BRAF inhibitors: Implications for patients with melanoma brain metastases.

Pharmacol Res 2018 09 13;135:265-267. Epub 2017 Nov 13.

The Department of Neurooncology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2017.11.013DOI Listing
September 2018

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

N Engl J Med 2018 Aug;379(8):722-730

From the University of Texas M.D. Anderson Cancer Center, Houston (H.A.T.); Moffitt Cancer Center and Research Institute, Tampa, FL (P.A.F., N.I.K.); University of California-San Francisco, San Francisco (A. Algazi), the Angeles Clinic and Research Institute, Los Angeles (O.H.), Stanford University Hospital, Palo Alto (R.P.T.), and the Department of Medical Oncology, City of Hope, Duarte (K.M.) - all in California; Dana-Farber Cancer Institute, Boston (F.S.H., D.A.R.); University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill (S.J.M.); University of Colorado Comprehensive Cancer Center, Aurora (K.L.); University of Michigan, Ann Arbor (C.D.L.); Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (M.A.P.), Roswell Park Cancer Institute, Buffalo (M.S.E., I.P.), and New York University, Lake Success (A.C.P.) - all in New York; Georgetown-Lombardi Comprehensive Cancer Center, Washington DC (M.B.A.); Winship Cancer Institute of Emory University, Atlanta (R.R.K.); University of Pittsburgh Medical Center, Pittsburgh (A.T.); Bristol-Myers Squibb, Princeton, NJ (J.J., A. Avila, S.D.); and Cleveland Clinic-Taussig Cancer Institute, Cleveland (A.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805453DOI Listing
August 2018

The biology and therapeutic management of melanoma brain metastases.

Biochem Pharmacol 2018 07 24;153:35-45. Epub 2017 Dec 24.

The Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2017.12.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959746PMC
July 2018

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience.

Breast Cancer Res Treat 2018 Jun 1;169(2):391-396. Epub 2018 Feb 1.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4684-3DOI Listing
June 2018

Oncolytic Virotherapy for Malignant Gliomas.

J Clin Oncol 2018 05 13;36(14):1440-1442. Epub 2018 Feb 13.

Peter A. Forsyth and Daniel Abate-Daga, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3192DOI Listing
May 2018

Reply to Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

Cancer 2018 05 15;124(10):2254-2255. Epub 2018 Mar 15.

Georgetown Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31261DOI Listing
May 2018

Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.

Cancer 2018 01 12;124(2):297-305. Epub 2017 Oct 12.

Georgetown Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30946DOI Listing
January 2018

Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Cancer Causes Control 2017 Jul 4;28(7):709-716. Epub 2017 Mar 4.

Division of Population Sciences, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-017-0871-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469709PMC
July 2017

Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Cancer Causes Control 2017 07;28(7):717-718

Division of Population Sciences, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-017-0893-zDOI Listing
July 2017

BRAF-MEK inhibition in melanoma brain metastases: a new hope.

Lancet Oncol 2017 07;18(7):836-837

Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30449-7DOI Listing
July 2017

Clinical outcomes from maximum-safe resection of primary and metastatic brain tumors using awake craniotomy.

Clin Neurol Neurosurg 2017 Jun 20;157:25-30. Epub 2017 Mar 20.

University of South Florida Morsani College of Medicine, 12901 Bruce B Downs Blvd, Tampa, FL 33612, USA; Departments of Neuro-Oncology, H. Lee Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2017.03.017DOI Listing
June 2017

Experimental Treatments for Leptomeningeal Metastases From Solid Malignancies.

Cancer Control 2017 Jan;24(1):42-46

Department of Neuro-Oncology, Moffitt Cancer Center and Department of Oncologic, University of South Florida Morsani College of Medicine, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481702400106DOI Listing
January 2017

A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.

Melanoma Res 2016 10;26(5):481-6

Departments of aTumor Biology bNeurooncology cAnatomic Pathology dCutaneous Oncology eMorsani Molecular Diagnostics Laboratory, Moffitt Cancer Center & Research Institute, Tampa fBascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida, USA gDepartment of Oncology, Tom Baker Cancer Center & University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502096PMC
October 2016

Analgesic use and the risk of primary adult brain tumor.

Eur J Epidemiol 2016 09 19;31(9):917-25. Epub 2016 Feb 19.

Department of Neurological Surgery, Vanderbilt University Medical Center, 691 Preston Building, Nashville, TN, 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10654-016-0129-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991947PMC
September 2016

Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Int J Cancer 2016 09 30;139(6):1195-201. Epub 2016 Apr 30.

The Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939138PMC
September 2016

M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma.

Neuro Oncol 2016 Mar 8. Epub 2016 Mar 8.

Department of Neuro-Oncology and Tumor Biology, Moffitt Cancer Center, Tampa, Florida (A.P., R.S.K., A.B.E., P.A.F.); Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada (B.M., F.Z., X.L., E.K., P.A.F.); Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida (M.M.R., G.M.); Center for Cancer Research, National Cancer Institute, Bethesda, Maryland (K.R.); Department of Immunology, Moffitt Cancer Center, Tampa, Florida (S.P.-T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933479PMC
March 2016

BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.

Sci Rep 2016 Feb 18;6:21710. Epub 2016 Feb 18.

Department of Neuro-Oncology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep21710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757860PMC
February 2016

In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.

Neuro Oncol 2015 Aug 20;17(8):1086-94. Epub 2015 Jan 20.

Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Canada (B.A.M., F.J.Z., A.N., X.L, E.U.K, P.A.F.); Department of Pediatrics, University of Calgary, Calgary, Canada (A.N.); Department of Oncology, University of Calgary, Calgary, Canada (A.N., P.A.F.); Department of Physiology & Pharmacology, University of Calgary, Calgary, Canada (E.U.K.); Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida (A.P., R.S.K, P.A.F.); Department of Molecular Genetics & Microbiology, University of Florida, Gainesville, Florida (G.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490869PMC
August 2015

LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases.

J Neurooncol 2015 Mar 18;122(1):121-6. Epub 2014 Dec 18.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL, 33612, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1685-xDOI Listing
March 2015

Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.

J Biol Chem 2015 Feb 23;290(6):3814-24. Epub 2014 Dec 23.

From the Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta T2N 4N2, Canada, the Departments of Neuro-Oncology, the Department of Oncological Sciences, University of South Florida College of Medicine, Tampa, Florida 33612

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M114.599373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319045PMC
February 2015

Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.

Cancer Res 2014 Dec 21;74(24):7260-73. Epub 2014 Oct 21.

Southern Alberta Cancer Research Institute, University of Calgary, Alberta, Canada. Clark H. Smith Brain Tumor Center, University of Calgary, Alberta, Canada. Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute and University of Southern Florida, Tampa, Florida.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-0876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281961PMC
December 2014

Reproductive factors and risk of primary brain tumors in women.

J Neurooncol 2014 Jun 4;118(2):297-304. Epub 2014 Apr 4.

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-014-1427-0
Publisher Site
http://dx.doi.org/10.1007/s11060-014-1427-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048769PMC
June 2014

Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.

PLoS One 2013 10;8(6):e66825. Epub 2013 Jun 10.

Departments of Oncology, Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066825PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677932PMC
February 2014

Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.

PLoS One 2013 6;8(6):e65801. Epub 2013 Jun 6.

Department of Oncology, Clark H. Smith Brain Tumor Center, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0065801PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675064PMC
January 2014

Toenail iron, genetic determinants of iron status, and the risk of glioma.

Cancer Causes Control 2013 Dec 31;24(12):2051-8. Epub 2013 Aug 31.

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-013-0281-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823695PMC
December 2013

Novel treatments for melanoma brain metastases.

Cancer Control 2013 Oct;20(4):298-306

Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481302000407DOI Listing
October 2013

Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps.

Cell Host Microbe 2013 Feb;13(2):169-80

Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB T2N 4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chom.2013.01.005DOI Listing
February 2013

Melanoma in the brain: biology and therapeutic options.

Melanoma Res 2012 Jun;22(3):177-83

Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida 33612, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/melanomaresearch/2012/06000/Mel
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CMR.0b013e328352dbefDOI Listing
June 2012

A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas.

Cancer 2011 Nov 31;117(21):4905-15. Epub 2011 Mar 31.

Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26123DOI Listing
November 2011

Leptomeningeal disease in oligodendroglial tumors: a population-based study.

J Neurooncol 2011 Sep 4;104(3):811-5. Epub 2011 Mar 4.

Clark H. Smith Brain Tumor Center, Tom Baker Cancer Center, Alberta Health Services, HRIC 2AA07, 3330 Hospital Dr NW, Calgary, AB, T2N 4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0551-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170119PMC
September 2011

Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy.

Trends Mol Med 2011 Aug 19;17(8):433-41. Epub 2011 Apr 19.

Departments of Oncology, Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, T2N 4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2011.03.004DOI Listing
August 2011

Public goods games with reward in finite populations.

J Math Biol 2011 Jul 24;63(1):109-23. Epub 2010 Sep 24.

Department of Mathematics, University of British Columbia, 1984 Mathematics Road, Vancouver, BC V6T 1Z2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00285-010-0363-7DOI Listing
July 2011

Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.

Cytokine Growth Factor Rev 2010 Apr-Jun;21(2-3):103-17. Epub 2010 May 18.

Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, Clark H. Smith Brain Tumor Center, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2010.04.001DOI Listing
September 2010

Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience.

J Neurooncol 2010 Feb 8;96(3):403-8. Epub 2009 Aug 8.

Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9977-2DOI Listing
February 2010

Susceptibility of mantle cell lymphomas to reovirus oncolysis.

Leuk Res 2010 Jan 3;34(1):100-8. Epub 2009 Aug 3.

Translational Research Laboratory, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.05.020DOI Listing
January 2010

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.

Cancer Res 2010 Jan 12;70(2):598-608. Epub 2010 Jan 12.

Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada T2N 4N1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1510DOI Listing
January 2010

Population-based study of pseudoprogression after chemoradiotherapy in GBM.

Can J Neurol Sci 2009 Sep;36(5):617-22

Department of Oncology, Tom Baker Cancer Centre, Alberta Cancer Board, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://www.bvsoncologia.org.uy/pdfs/urucan/canjneurolsci3661
Web Search
http://dx.doi.org/10.1017/s0317167100008131DOI Listing
September 2009

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.

J Neurooncol 2008 Aug 9;89(1):97-103. Epub 2008 Apr 9.

Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-008-9593-6
Publisher Site
http://dx.doi.org/10.1007/s11060-008-9593-6DOI Listing
August 2008

Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors.

Clin Cancer Res 2008 Feb;14(4):1218-27

Department of Oncology, University of Calgary, the Tom Baker Cancer Centre, and the Clark H. Smith Brain Tumour Research Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-07-1330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844789PMC
February 2008

Proteolytic disassembly is a critical determinant for reovirus oncolysis.

Mol Ther 2007 Aug 22;15(8):1512-21. Epub 2007 May 22.

Department of Medical Sciences, Clark Smith Integrative Brain Tumor Research Center, Southern Alberta Cancer Research Institute, University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.mt.6300207DOI Listing
August 2007

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

Mol Ther 2007 Jan;15(1):123-30

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa Health Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.mt.6300039DOI Listing
January 2007

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

J Neurooncol 2006 Jul 25;78(3):295-302. Epub 2006 Apr 25.

Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-005-9098-5
Publisher Site
http://dx.doi.org/10.1007/s11060-005-9098-5DOI Listing
July 2006

Recent progress in the battle between oncolytic viruses and tumours.

Nat Rev Cancer 2005 Dec;5(12):965-76

Centre for Cancer Therapeutics, Ottawa Health Research Institute, 503 Smyth Road, Ottawa, Ontario, Canada K1H 8L6.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrc1750
Publisher Site
http://dx.doi.org/10.1038/nrc1750DOI Listing
December 2005

Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Cancer Res 2005 Nov;65(21):9982-9990

Departments of Oncology, Clinical Neurosciences, and Biochemistry and Molecular Biology, University of Calgary, and Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-05-1201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373463PMC
November 2005

Imaging correlates of molecular signatures in oligodendrogliomas.

Clin Cancer Res 2004 Jul;10(13):4303-6

Department of Clinical Neurological Sciences, University of Western Ontario and London Regional Cancer Centre, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-0209DOI Listing
July 2004

Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?

Cancer J 2003 May-Jun;9(3):214-21

Department of Oncology & Clinical Neurosciences, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta.

View Article

Download full-text PDF

Source
December 2003

Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.

Clin Cancer Res 2003 Dec;9(16 Pt 1):5952-61

Department of Medical Biochemistry and Southern Alberta Cancer Research Center, The University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
December 2003

Prophylactic anticonvulsants in patients with brain tumour.

Can J Neurol Sci 2003 May;30(2):106-12

Department of Oncology & Clinical Neurosciences, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s0317167100053361DOI Listing
May 2003

Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.

Mol Cancer Res 2003 Mar;1(5):333-45

School of Biological Sciences, University of East Anglia, Norwich, Norfolk, United Kingdom.

View Article

Download full-text PDF

Source
March 2003